Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 19730115)

1.

A review of sleep disturbance in hepatitis C.

Sockalingam S, Abbey SE, Alosaimi F, Novak M.

J Clin Gastroenterol. 2010 Jan;44(1):38-45. doi: 10.1097/MCG.0b013e3181b314ea. Review.

PMID:
19730115
2.

Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review.

Quelhas R, Lopes A.

J Psychiatr Pract. 2009 Jul;15(4):262-81. doi: 10.1097/01.pra.0000358313.06858.ea. Review.

PMID:
19625882
3.

Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review.

Dieperink E, Willenbring M, Ho SB.

Am J Psychiatry. 2000 Jun;157(6):867-76. Review.

PMID:
10831463
4.
5.

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.

Schaefer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, Schindlbeck N, Heldwein W, Soyka M, Grunze H, Koenig A, Loeschke K.

Hepatology. 2003 Feb;37(2):443-51.

PMID:
12540795
6.

Association between apolipoprotein E epsilon4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C.

Gochee PA, Powell EE, Purdie DM, Pandeya N, Kelemen L, Shorthouse C, Jonsson JR, Kelly B.

Psychosomatics. 2004 Jan-Feb;45(1):49-57.

PMID:
14709760
7.

Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update.

Sockalingam S, Links PS, Abbey SE.

J Viral Hepat. 2011 Mar;18(3):153-60. doi: 10.1111/j.1365-2893.2010.01393.x. Epub 2010 Nov 10. Review.

PMID:
21070503
8.

Interferon for hepatitis C patients with psychiatric disorders.

Asnis GM, De La Garza R, Rego SA, Henderson MA, Reinus JF.

Am J Psychiatry. 2004 Dec;161(12):2332; author reply 2332-4. No abstract available.

PMID:
15569920
9.

Interferon for hepatitis C patients with psychiatric disorders.

Rifai MA, Bozorg B, Rosenstein DL.

Am J Psychiatry. 2004 Dec;161(12):2331-2; author reply 2332-4. No abstract available.

PMID:
15569919
10.

An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.

Jacobson KR, Murray K, Zellos A, Schwarz KB.

J Pediatr Gastroenterol Nutr. 2002 Jan;34(1):52-8.

PMID:
11753165
11.

Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.

Maddock C, Baita A, Orrù MG, Sitzia R, Costa A, Muntoni E, Farci MG, Carpiniello B, Pariante CM.

J Psychopharmacol. 2004 Mar;18(1):41-6.

PMID:
15107183
12.

[Treatment of chronic hepatitis C in special groups].

Bourlière M, Halfon P, Portal I.

Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B238-47. Review. French. No abstract available.

PMID:
12180296
13.

Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?

Schaefer M, Heinz A, Backmund M.

Addiction. 2004 Sep;99(9):1167-75. Review.

PMID:
15317637
14.
15.

Enhancing the response to interferon-alpha.

Begemann F, Jablonowski H.

J Clin Virol. 1999 Jun;13(1-2):1-7.

PMID:
10405886
16.

The effect of early treatment in children with chronic hepatitis.

Hartman C, Berkowitz D, Rimon N, Shamir R.

J Pediatr Gastroenterol Nutr. 2003 Sep;37(3):252-7.

PMID:
12960645
17.

Natural interferon alpha treatment and interferon alpha receptor 2 levels in acute hepatitis C.

Ohata K, Yano K, Yatsuhashi H, Daikoku M, Koga M, Eguchi K, Yano M.

Dig Dis Sci. 2004 Feb;49(2):289-94.

PMID:
15104372
18.

Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.

Hauser P.

Gastroenterol Clin North Am. 2004 Mar;33(1 Suppl):S35-50.

PMID:
15081102
19.

Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.

Kraus MR, Schäfer A, Faller H, Csef H, Scheurlen M.

Aliment Pharmacol Ther. 2002 Jun;16(6):1091-9.

20.

Effect of ribavirin, in combination with interferon in patients with hepatitis C, on the bleeding risk associated with selective serotonin reuptake inhibitors.

Honda T, Katano Y, Toyoda H, Hayashi K, Ishigami M, Nakano I, Goto H, Yamamoto K, Takamatsu J.

J Clin Psychiatry. 2008 Apr;69(4):679-80. No abstract available.

PMID:
18507491
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk